Try our mobile app

General information

Sistema PJSC FC is a publicly-listed investment company incorporated in Russia. The Company owns a diverse set of public and private companies which it holds in two distinct portfolios: Core assets and Developing assets.
  • Dividend yield for the last twelve months 1.6%
  • Free cash flow yield -65.7% (LTM)
  • Share price is 146.2% higher than minimum and 29.9% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (6.4x vs
    )

Key Financials (Download financials)

Ticker: AFKS
Share price, RUB:  (-1.1%)25.2855
year average price 17.49  


year start price 14.82 2023-04-20

min close price 14.70 2023-05-04

max close price 25.56 2024-04-17

current price 25.29 2024-04-18
Common stocks: 9 650 000 000

Dividend Yield:  1.6%
FCF Yield LTM: -65.7%
EV / LTM EBITDA: 6.4x
EV / EBITDA annualized: 12.5x
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 244 005
Net Debt (m RUB): 1 451 048
EV (Enterprise Value): 1 695 053
EBITDA LTM (m RUB): 266 200
EV / LTM EBITDA: 6.4x
Average daily trading volume for the week, RUB mln: 4584.34

Revenue and EBITDA

Quarterly values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

Valuation through assets (as of the end of 2023 q4)


Sistema PJSC FC has stakes in the following companies

Company Ticker Share Cap EBITDA LTM Net Debt
Segezha Group SGZH 72.0% 60 626 9 281 140 530
MTS MTSS 50.3% 536 298 206 662 441 013
OZON OZON 32.4% 829 261
Etalon ETLN 29.8% 36 493
Influence at AFKS 592 960 215 943 581 543
mln RUB
 
         Net Debt AFKS 1 451 048
         Net Debt in listed companies 581 543
      Net Debt in not listed companies 869 505
 
         EBITDA LTM AFKS 266 200
         EBITDA LTM in listed companies 215 943
         EBITDA LTM in not listed companies 50 257
      EV evaluation in not listed companies (x5) 251 285
 
      Binnopharm Cap revaluation 41 600
 
   Cap in not listed companies, min -300k -576 620
   Cap in listed companies 592 960
 
AFKS Cap evaluation through assets 292 960
AFKS Cap 244 005
 
Current price discount 16.7%
Historical price discount 7.9%
 
Growth potential (0.921 / 0.833 - 1) +10.6%
chart technology by TradingView
chart technology by TradingView
More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company